Loading clinical trials...
Loading clinical trials...
The primary purpose of this study is to evaluate the safety and efficacy of varenicline given for a twelve week treatment period in comparison with placebo and Zyban for smoking cessation.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pfizer
NCT06598397 · Human Immunodeficiency Virus (HIV), Smoking Cessation
NCT07441928 · Smoking Cessation, Schizophenia Disorder
NCT07080788 · Smoking Cessation Intervention, Pain, and more
NCT05846841 · Physician's Role, Smoking Cessation, and more
NCT07210567 · Smoking Cessation
Pfizer Investigational Site
Palo Alto, California
Pfizer Investigational Site
San Diego, California
Pfizer Investigational Site
Denver, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions